| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $740.8M | -20.6% |
| Cost of Revenue | $491.6M | -27.9% |
| Gross Profit | $249.3M | -0.5% |
| R&D Expense | $83.3M | -5.8% |
| SG&A Expense | $66.2M | +17.6% |
| Operating Income | -$33.3M | +59.9% |
| Pre-tax Income | -$19.1M | +76.7% |
| Income Tax | $85.6M | +756.9% |
| Net Income | -$104.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $176.7M | +20.6% |
| Short-term Investments | $106.9M | +32.1% |
| Accounts Receivable | $185.1M | -33.3% |
| Inventory | $248.9M | -16.9% |
| Current Assets | $748.0M | -10.3% |
| Total Assets | $847.1M | -16.9% |
| Current Liabilities | $264.3M | -23.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $56.9M | +514.0% |
| Capital Expenditures | $5.8M | +0.7% |
| Investing Cash Flow | -$27.4M | +65.5% |
| Financing Cash Flow | $797K | +103.3% |
| Free Cash Flow | $51.1M | +362.0% |
| -51.9% |
| EPS (Basic) | -$3.57 | -50.0% |
| EPS (Diluted) | -$3.57 | -50.0% |
| Total Liabilities |
| $311.6M |
| -21.9% |
| Stockholders' Equity | $535.5M | -13.7% |